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Progress has recently been made in understanding the genetic basis of schizophrenia and other psychiatric dis-
orders. Longitudinal studies are complicated by participant dropout, which could be related to the presence of psy-
chiatric problems and associated genetic risk. We tested whether common genetic variants implicated in
schizophrenia were associated with study nonparticipation among 7,867 children and 7,850 mothers from the
Avon Longitudinal Study of Parents and Children (ALSPAC; 1991–2007), a longitudinal population cohort study.
Higher polygenic risk scores for schizophrenia were consistently associated with noncompletion of questionnaires
by study mothers and children and nonattendance at data collection throughout childhood and adolescence (ages
1–15 years). These associations persisted after adjustment for other potential correlates of nonparticipation. Re-
sults suggest that persons at higher genetic risk for schizophrenia are likely to be underrepresented in cohort stud-
ies, which will underestimate risk of this and related psychiatric, cognitive, and behavioral phenotypes in the
population. Statistical power to detect associations with these phenotypes will be reduced, while analyses of
schizophrenia-related phenotypes as outcomes may be biased by the nonrandom missingness of these pheno-
types, even if multiple imputation is used. Similarly, in complete-case analyses, collider biasmay affect associations
between genetic risk and other factors associated with missingness.
Avon Longitudinal Study of Parents and Children; attrition bias; cohort studies; genetic risk; longitudinal studies;
schizophrenia; study nonparticipation
Abbreviations: ALSPAC, Avon Longitudinal Study of Parents andChildren; GWAS, genome-wide association study; IQ, intelligence
quotient; MDD, major depressive disorder; PRS, polygenic risk scores; SNP, single-nucleotide polymorphism.
Schizophrenia is a highly heritable and severely impairing
neurodevelopmental disorder with onset typically in early
adulthood. In a recent genome-wide association study (GWAS)
meta-analysis of 34,241 schizophrenia cases, 45,604 con-
trols, and 1,235 parent-offspring trios, the Schizophrenia
Working Group of the Psychiatric Genomics Consortium re-
ported 128 independent genome-wide signiﬁcant single-
nucleotide polymorphisms (SNPs) associated with risk of
this disorder (1). Given that schizophrenia has a relatively
low lifetime morbidity risk of about 0.7% in the general pop-
ulation (2), population-based cohort samples are unlikely to
include many affected individuals. Such longitudinal studies
may also be limited by nonparticipation at given time points,
or even complete loss to follow-up.
There are multiple factors associated with nonparticipation
in cohort studies, including socioeconomic adversity, male
sex, and cognitive, emotional, and behavioral problems (3–6).
Given that many of these factors are associated with risk of
schizophrenia (7, 8), persons at higher risk for this disorder
may also be more likely to be lost to follow-up, even before
illness onset. Studies show that genetic risk of schizophrenia
overlaps with risks of other psychiatric conditions, including
bipolar disorder, major depressive disorder (MDD), attention-
deﬁcit/hyperactivity disorder, autism spectrum disorder,
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and intellectual disability (9–12). Given the breadth of
phenotypic-genetic overlap, it is plausible that schizophrenia
genetic risk predisposes people to a broad range of psychopa-
thology that could be at subthreshold levels with regard to
disorder diagnosis but result in higher levels of nonparticipa-
tion in longitudinal studies. Thus, schizophrenia could be re-
lated to nonparticipation in cohort studies either through
clinical phenotypic features associated with the disorder or
through genetic risk factors that affect an individual’s pre-
morbid state.
Missing data in longitudinal studies are associated with a
loss of statistical power, but missing data may also cause bias
in estimation. When an outcome affects participation, the as-
sumption that outcome data are missing at random will not
hold true. A given analysis is likely to be biased if the out-
come variable is related to the probability of selection, con-
ditional on the other variables included in the model (i.e., the
outcome variable is missing not-at-random). Therefore, if in-
creased risk of psychiatric, behavioral, or cognitive pheno-
types is associated with nonparticipation and missing data
in longitudinal studies, this could lead to biases in analyses
which examine risk factors for psychiatric phenotypes. Bias
due to missing data can also be looked upon as a form of col-
lider bias (13, 14), where conditioning on “participation” or
“being a complete case” can induce an association between
any 2 factors that cause nonparticipation. So if increased ge-
netic risk of a psychiatric phenotype causes nonparticipation,
then complete-case analyses (i.e., restriction of analyses to
samples with no missing data) could induce associations be-
tween genetic risk score and other risk factors for nonpartic-
ipation (e.g., sex, socioeconomic position).
To date, the issue of whether genetic risk of schizophrenia
is directly associated with nonparticipation has not been ex-
amined in longitudinal data sets. However, it is an important
question that needs to be addressed, especially in light of the
recent increased interest in leveraging longitudinal popula-
tion cohort data to investigate the genetic architecture of psy-
chiatric and behavioral phenotypes (15). Our main aim in this
study was to determine whether genetic risk from common
genetic variants, as estimated by polygenic risk scores (PRS)
for schizophrenia, based on the largest GWAS conducted to
date (1), were associated with nonreturn of questionnaire data
by children and parents and with nonattendance at clinic data
collection assessments. We used data from a longitudinal
population cohort study, the Avon Longitudinal Study of Par-
ents and Children (ALSPAC). It was postulated that higher
PRS in ALSPAC children and mothers would be associated
with increased rates of nonparticipation. A secondary aim
was to determine whether polygenic risk of schizophrenia was
associated with nonparticipation above and beyond the asso-
ciations of several known correlates of missing data: 1) family
history of psychopathology (i.e., schizophrenia and MDD),
2) family socioeconomic factors, and 3) the index child’s
sex and behavioral and emotional problems.
METHODS
ALSPAC is a large, well-characterized longitudinal data
set (4, 16). ALSPAC originally recruited 14,541 pregnant
women resident in Avon, United Kingdom, with expected
delivery dates between April 1, 1991, and December 31,
1992. Among these pregnancies, there were 14,062 liveborn
children, of whom 13,988 were alive at 1 year of age. An ad-
ditional 713 children who would have been eligible but
whose mothers did not enroll during pregnancy were enrolled
after age 7 years, resulting in a total sample of 14,701 chil-
dren alive at age 1 year. The study website contains details
on all available data through a fully searchable data dictionary
(17). Ethical approval for the study was obtained from the
ALSPAC Ethics and Law Committee and local research eth-
ics committees.
For the purposes of this study, only children who survived
to age 1 year, had been enrolled in the study during the ﬁrst
phase of data collection, and had genotype datawere included
in the sample. This resulted in a sample of 7,867 children
with imputed data for 2,543,887 SNPs after all quality control
procedures were implemented. Imputation of genetic data
was performed using HapMap release 22 in MACH 1.0.16
(18). Maternal genetic data were available for 7,850 mothers
in the sample—a total of 2,543,887 SNPs after quality con-
trol. Details on quality control protocols for the genetic data
are provided elsewhere (19). Genetic data for mother-child
dyads were available for 5,262 mother-child pairs.
Measures of participation
Yes/no variables were generated for whether each child
had data available at each data collection time point (at the
approximate ages of 7, 10, 13, and 15 years) from 3 sources:
clinic attendance, mother-completed postal questionnaires,
and child-completed postal questionnaires. Additionally, data
on participation at 2 earlier time points for mother-completed
questionnaires at ages 1 and 4 years (data available: yes/no)
were used. These time points were selected to cover a reason-
able spread of ages across childhood and adolescence for the
study child, for the 3 types of data collection sources. The postal
questionnaires contained questions covering a range of demo-
graphic, developmental, psychological, and health issues. Data
collected at clinical assessments included cognitive and physi-
ological measures (e.g., language abilities, blood pressure, lung
function). Figure 1 shows the number of persons with available
data for each time point. Additional information on how data
were collected over time and how many people responded
over time is available in the main study publications (4, 16).
Potential correlates of nonparticipation
Family history, child-level, and socioeconomic variables
previously shown to be associated with missing data were
examined in relation to the above measures of participation.
Binary variables for the presence of psychosis/schizophrenia
(in ﬁrst- or second-degree relatives) and maternal history of
MDD were used as measures of family history of psychopa-
thology. These were assessed using mother-completed ques-
tionnaires, which were completed during pregnancy with the
index child. Child-level variables examined were sex and a
total score for behavioral and emotional difﬁculties, as as-
sessed by maternal report using the Strengths and Difﬁculties
Questionnaire, at the approximate age of 4 years (20). The fol-
lowing socioeconomic variables were also examined: highest
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maternal educational level (Certiﬁcate of Secondary Education,
vocational, O-levels, A-levels, or undergraduate degree),
home ownership (yes/no), and parental socioeconomic
position. Three socioeconomic categories were deﬁned (low:
unskilled workers/unemployed; medium: manual and non-
manual skilled/partially skilled workers; high: professional
and managerial workers) on the basis of whichever reported
parental occupation was higher-level; the occupations were
classiﬁed using the United Kingdom Standard Occupational
Classiﬁcation (21).
Discovery sample and calculating PRS
We used the largest schizophrenia GWAS published to date
(1) to derive PRS in ALSPAC children and mothers. The
P value threshold (PT) used to deﬁne risk alleles was P <
0.05, the threshold at which PRS maximally predict caseness
in independent samples (9). Scores were calculated separately
for ALSPAC children and mothers using imputed SNPs. First,
SNPs in the discovery sample were ﬁltered for a minor allele
frequency greater than 1% and an INFO imputation score (a
measure of the certainty and quality of the imputation results)
greater than 0.9 (18). Linkage disequilibrium-based clumping
was performed for SNPs overlapping discovery and ALSPAC
samples in PLINK software, version 1.9 (22), using the follow-
ing parameters: --clump-p1 0.5, --clump-r2 0.25, and --clump-
kb 500.Additional quality control procedureswere subsequently
performed that checked for strand mismatches and substantial
differences in allele frequencies (>0.1) between the Psychiatric
Genomics Consortium schizophrenia sample (1) and the sam-
ples of ALSPAC children and mothers. Where appropriate,
strand mismatches were corrected using the “ﬂip” command
in PLINK. Schizophrenia PRS were subsequently calculated
for ALSPAC children and mothers using the --score function
in PLINK. Scores were based on 35,768 SNPs in children and
35,756 SNPs in mothers. The scores were normally distribu-
ted and were standardized using z-score transformation to aid
interpretation of the results.
Statistical analysis
Analyses were performed in Stata, version 13.1 (StataCorp
LP, College Station, Texas). Logistic regression analyses were
used to estimate odds ratios and 95% conﬁdence intervals for
missingness per 1-standard-deviation increase in PRS. For
each test, the Nagelkerke pseudo-R2 value is presented as an
estimate of the amount of variance in outcome (missingness)
explained by PRS. Analyses were performed separately for
child PRS and maternal PRS for each of the 3 types of data
collection (clinic attendance and child- and mother-completed
questionnaires). Secondary analyses explored the addition of
covariates, unique child and maternal associations, and wheth-
er the association with PRS changed over time. The latter anal-
ysis was conducted using generalized estimating equations,
including an interaction term for the interaction of PRS with
age, to examine change in the association over time.
RESULTS
Table 1 displays descriptive statistics for covariates in the
study sample, stratiﬁed by whether children had genetic
data. Persons with genetic data were more likely to have a
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Figure 1. Data availability in a sample of mothers and children with genetic data from the Avon Longitudinal Study of Parents and Children, 1991–
2007. Black indicates persons who participated in data collection at a given time point; gray indicates persons with missing data.
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higher socioeconomic position, mothers with higher levels of
education, parents who owned their own home, lower risk of
maternal MDD, higher risk of a family history of psychosis,
and lower scores on the Strengths and Difﬁculties Question-
naire than persons without genetic data.
There was strong evidence that higher schizophrenia PRS
in the children were associated with missing data for all mea-
sures and time points (see Table 2). The odds ratios reﬂected
an increased likelihood of missing data per 1-standard-
deviation increase in schizophrenia PRS. PRS in mothers
were similarly associated with missing data for all time points
(see Table 2). The mean differences in PRS for persons with
and without missing data are shown in Figures 2 and 3 for
PRS in children and mothers, respectively.
Figures 4 and 5 display mean PRS for schizophrenia in
children and mothers, depending on the cumulative number
of missing data points. A linear regression of the number of
missing data points on schizophrenia PRS showed that PRS
were associated with an increase of 0.07 missing data points
(0.08 in mothers) per 1-standard-deviation increase in PRS.
Results of multivariable regression analyses of the asso-
ciation between schizophrenia PRS and missing data, after
adjustment for family history of MDD or schizophrenia,
child variables (sex and total Strengths and Difﬁculties Ques-
tionnaire problems), and socioeconomic variables (family
socioeconomic position, maternal education, and home own-
ership), can be found in Table 3. Complete data on all vari-
ables were available for 5,601 children and 5,347 mothers.
PRS for schizophrenia in children continued to show an
association with availability of data for the majority of data
collection time points (except mother-completed question-
naires at age 4 years and child-completed questionnaires at
Table 1. Distribution of the Study Sample According to Availability of Children’s Genetic Data, Avon Longitudinal
Study of Parents and Children, 1991–2007
Characteristic
Availability of Child’s Genetic Data
Statistica
Available Not Available
No. % No. % χ2 P Value
Sex 0.20 0.66
Female 3,819 48.5 2,856 48.2
Male 4,048 51.5 3,074 51.8
Family socioeconomic statusb 80.4 3.5e−18
Low 182 2.6 175 4.0
Medium 4,809 68.7 3,232 74.3
High 2,013 28.7 944 21.7
Home ownership 313.3 4.1e−70
Renting/other 1,581 20.9 1,848 34.9
Owned home 5,989 79.1 3,446 65.1
Maternal education 298.1 2.7e−63
CSE 1,193 16.1 1,279 26.3
Vocational 666 9.0 544 11.2
O-levels 2,573 34.8 1,668 34.3
A-levels 1,836 24.8 924 19.1
Degree 1,134 15.3 442 9.1
Family history of psychosis 53.4 2.7e−13
No 6,712 90.4 4,606 94.1
Yes 715 9.6 291 5.9
Maternal history of MDD 20.7 5.7e−6
No 6,819 92.0 4,376 89.6
Yes 596 8.0 510 10.4
SDQ total scorec,d 8.8 (4.6) 9.2 (4.6)
Abbreviations: CSE, Certificate of Secondary Education; MDD, major depressive disorder; SDQ, Strengths and
Difficulties Questionnaire.
a Descriptive statistics are based on 7,867 persons with genetic data available for analysis and 5,930 persons
without genetic data in the analyses.
b Low: unskilled worker/unemployed; medium: manual or nonmanual skilled/partially skilled worker; high:
professional or managerial worker.
c Values are presented as mean (standard deviation).
d t =−3.8; P = 1.2e−4.
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Table 2. Association of Schizophrenia Polygenic Risk ScoresWith Missing Data Among Children andMothers From
the Avon Longitudinal Study of Parents and Children, 1991–2007
Source of Data and
Age, years
Child PRS (n = 7,867) Maternal PRS (n = 7,850)
OR 95% CI P Value Pseudo-R2 OR 95% CI P Value Pseudo-R2
Clinic attendance
7 1.16 1.10, 1.22 2.0e−8 0.0035 1.17 1.11, 1.22 1.0e−8 0.0042
10 1.14 1.08, 1.19 1.5e−7 0.0028 1.14 1.09, 1.19 3.0e−8 0.0030
13 1.14 1.09, 1.20 1.0e−8 0.0032 1.14 1.09, 1.19 2.0e−8 0.0030
15 1.14 1.09, 1.19 1.0e−8 0.0031 1.16 1.11, 1.21 1.0e−8 0.0038
Mother-completed questionnaire
1 1.12 1.04, 1.19 1.3e−3 0.0017 1.11 1.04, 1.18 9.3e−4 0.0016
4 1.10 1.04, 1.16 7.8e−4 0.0014 1.16 1.10, 1.22 5.0e−8 0.0036
7 1.12 1.07, 1.18 4.3e−6 0.0023 1.13 1.08, 1.18 5.7e−7 0.0026
10 1.11 1.06, 1.16 2.8e−5 0.0018 1.14 1.09, 1.20 1.0e−8 0.0032
13 1.11 1.06, 1.17 5.1e−6 0.0020 1.12 1.07, 1.17 5.8e−7 0.0024
15 1.10 1.06, 1.15 1.2e−5 0.0018 1.12 1.07, 1.17 1.1e−6 0.0022
Child-completed questionnaire
7 1.07 1.02, 1.12 7.0e−3 0.0007 1.08 1.03, 1.13 1.1e−3 0.0010
10 1.11 1.06, 1.17 3.1e−5 0.0018 1.15 1.10, 1.21 1.0e−8 0.0034
13 1.12 1.07, 1.17 7.9e−7 0.0023 1.13 1.08, 1.18 2.1e−7 0.0025
15 1.15 1.10, 1.20 1.0e−8 0.0033 1.12 1.07, 1.17 1.0e−6 0.0022
Abbreviations: CI, confidence interval; OR, odds ratio; PRS, polygenic risk scores.
–0.100
–0.050
0.000
0.050
0.100
0.150
7 10 13 15 1 4 7 10 13 15 7 10 13 15
Child-Completed
Questionnaire
M
ea
n 
z 
Sc
or
e
Source of Data and Age, years
Mother-Completed QuestionnaireClinic Attendance
Figure 2. Polygenic risk scores (mean z score) for schizophrenia among children from theAvon Longitudinal Study of Parents andChildren (1991–
2007), depending on data availability. White bars represent persons with data available; gray bars represent persons with missing data. Error bars
show standard errors.
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Figure 3. Polygenic risk scores (mean z score) for schizophrenia among mothers from the Avon Longitudinal Study of Parents and Children
(1991–2007), depending on data availability. White bars represent persons with data available; gray bars represent persons with missing data.
Error bars show standard errors.
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Figure 4. Polygenic risk scores (mean z score) for schizophrenia among children from the Avon Longitudinal Study of Parents andChildren (1991–
2007), according to the number of missing data points. The x-axis displays categories of persons with no missing data, missing data for only 1 time
point, missing data for 1–2 time points, missing data for 1–3 time points, and so on. Error bars show standard errors.
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Figure 5. Polygenic risk scores (mean z score) for schizophrenia among mothers from the Avon Longitudinal Study of Parents and Children
(1991–2007), according to the number of missing data points. The x-axis displays categories of persons with no missing data, missing data for
only 1 time point, missing data for 1–2 time points, missing data for 1–3 time points, and so on. Error bars show standard errors.
Table 3. Association of Schizophrenia Polygenic Risk ScoresWith Missing Data AmongChildren andMothers, After
Adjustment for Known Correlates of Study Nonparticipation,a Avon Longitudinal Study of Parents and Children,
1991–2007
Source of Data and
Age, years
Child PRS (n = 5,601) Maternal PRS (n = 5,347)
OR 95% CI P Value Pseudo-R2 OR 95% CI P Value Pseudo-R2
Clinic attendance
7 1.15 1.07, 1.24 1.9e−4 0.0029 1.18 1.10, 1.26 1.4e−6 0.0043
10 1.13 1.06, 1.20 3.8e−4 0.0022 1.13 1.06, 1.20 2.8e−4 0.0023
13 1.15 1.08, 1.21 3.6e−6 0.0031 1.09 1.03, 1.16 2.7e−3 0.0014
15 1.15 1.09, 1.22 7.7e−7 0.0032 1.13 1.06, 1.19 4.2e−5 0.0023
Mother-completed questionnaire
1 1.24 1.06, 1.44 6.2e−3 0.0048 1.10 0.96, 1.27 0.17 0.0011
4 1.01 0.90, 1.14 0.88 0.0000 1.27 1.12, 1.44 1.5e−4 0.0068
7 1.11 1.03, 1.20 9.0e−3 0.0016 1.10 1.02, 1.19 0.013 0.0014
10 1.09 1.02, 1.17 0.013 0.0012 1.13 1.05, 1.20 6.5e−4 0.0022
13 1.08 1.02, 1.15 0.013 0.0010 1.10 1.04, 1.17 2.3e−3 0.0015
15 1.11 1.05, 1.18 4.5e−4 0.0018 1.11 1.05, 1.18 5.5e−4 0.0017
Child-completed questionnaire
7 1.04 0.97, 1.10 0.25 0.0002 1.03 0.97, 1.10 0.30 0.0002
10 1.10 1.03, 1.19 6.5e−3 0.0015 1.18 1.10, 1.26 4.9e−6 0.0040
13 1.11 1.04, 1.18 9.4e−4 0.0017 1.12 1.05, 1.19 3.7e−4 0.0021
15 1.15 1.09, 1.22 6.0e−7 0.0032 1.10 1.04, 1.17 7.0e−4 0.0015
Abbreviations: CI, confidence interval; OR, odds ratio; PRS, polygenic risk scores.
a Family history of schizophrenia or depression, child sex and behavioral/emotional problems, family socioeconomic
position, maternal educational level, and home ownership.
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age 7 years), even after accounting for the known correlates
of missing data in longitudinal research. Similar results were
found for PRS calculated in mothers (see Table 3), with
strong evidence of association between maternal PRS and
data availability at the majority of data collection time points,
after accounting for the known correlates of nonparticipation.
On the whole, effect sizes for the association of PRS with
availability of data at the collection time points were not
changed upon the addition of these correlates to the models,
although the evidence for association was marginally stron-
ger than in the unadjusted models. (See Web Table 1, avail-
able at http://aje.oxfordjournals.org/, for results of unadjusted
analyses conﬁned to persons with no missing data.)
Secondary analyses
In order to further examine the source of the genetic asso-
ciation with nonparticipation, we repeated the analyses while
including both child and maternal PRS in the same model, for
child-mother pairs with available genetic data (n = 5,262).
The correlation between children’s and mothers’ scores was
0.509. As can be seen from Table 4, children’s PRS were as-
sociated with missing data independently of the association
of maternal PRS for the majority of data collection time
points (except for mother-completed questionnaires at age
4 years). There was no evidence of association of maternal
PRS with nonparticipation, above and beyond the variance
shared with child PRS. On the whole, odds ratios were higher
for child PRS than for maternal PRS.
Finally, we estimated the population-averaged association
between schizophrenia PRS and missing data across time
points and examined whether this changed over time (see
Web Table 2). The results suggested that the association of
child PRS with child-completed questionnaires increased
over time, but there was no evidence that the association
with other data sources changed over time.
DISCUSSION
The results of this study show a consistent pattern of associ-
ation between increased PRS for schizophrenia in children and
mothers from theALSPACgeneral population sample and non-
participation in data collection at time points across ages 1–15
years. The magnitudes of these associations remained similar
after adjustment for several known correlates of nonparticipa-
tion (i.e., family history of schizophrenia or depression, child
sex and behavioral/emotional problems, family socioeconomic
position, maternal educational level, and home ownership (3–
6)). Together, these results suggest that analyses of schizo-
phrenia (and genetically related psychiatric phenotypes) as
outcomes in longitudinal population cohort studies are likely
to be underpowered, given that personswith a genetic predispo-
sition to these phenotypes will be underrepresented in longitu-
dinal population cohorts. They also indicate that some analyses
of schizophrenia and related outcomes may be biased because
data for these outcomes may be missing not-at-random.
Given the low prevalence of schizophrenia in the popula-
tion (2) and the high pleiotropy of genetic risk of schizophre-
nia (10–12), the results further imply that nonparticipation
in longitudinal research may be associated with other psychi-
atric disorders (e.g., MDD or attention-deﬁcit/hyperactivity
disorder), as well as subclinical psychopathology or related
phenotypes (e.g., personality traits, cognitive function),
Table 4. Association of Schizophrenia Polygenic Risk ScoresWith Missing Data Among Children andMothers, After
Adjustment for Shared Associations, Avon Longitudinal Study of Parents and Children, 1991–2007
Source of Data and
Age, years
Child PRS (n = 5,262) Maternal PRS (n = 5,262)
OR 95% CI P Value Pseudo-R2 OR 95% CI P Value Pseudo-R2
Clinic attendance
7 1.12 1.04, 1.21 3.6e−3 0.0016 1.07 1.00, 1.16 0.066 0.0006
10 1.14 1.06, 1.23 5.3e−4 0.0021 1.03 0.96, 1.11 0.43 0.0001
13 1.15 1.08, 1.23 4.0e−5 0.0025 1.02 0.95, 1.09 0.62 <0.0001
15 1.11 1.04, 1.19 1.1e−3 0.0015 1.06 1.00, 1.13 0.056 0.0005
Mother-completed questionnaire
1 1.12 1.01, 1.24 0.033 0.0013 1.05 0.95, 1.16 0.36 0.0003
4 1.07 0.98, 1.17 0.11 0.0006 1.04 0.96, 1.13 0.33 0.0002
7 1.16 1.07, 1.25 1.5e−4 0.0026 0.97 0.90, 1.04 0.35 0.0002
10 1.13 1.05, 1.21 9.3e−4 0.0018 1.00 0.93, 1.07 0.97 <0.0001
13 1.09 1.02, 1.16 0.016 0.0009 1.04 0.97, 1.11 0.26 0.0002
15 1.10 1.04, 1.18 2.5e−3 0.0013 1.00 0.94, 1.07 0.91 <0.0001
Child-completed questionnaire
7 1.07 1.00, 1.14 0.048 0.0006 0.97 0.91, 1.04 0.34 0.0001
10 1.11 1.03, 1.20 4.9e−3 0.0013 1.05 0.98, 1.13 0.19 0.0003
13 1.13 1.05, 1.21 4.9e−4 0.0018 1.03 0.96, 1.10 0.38 0.0001
15 1.17 1.09, 1.24 2.1e−6 0.0031 1.02 0.96, 1.09 0.55 0.0001
Abbreviations: CI, confidence interval; OR, odds ratio; PRS, polygenic risk scores.
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even in the absence of a psychiatric diagnosis. The observed
association between genetic risk of schizophrenia and study
nonparticipation is likely to be the result of an inﬂuence of
schizophrenia risk alleles on phenotypes beyond those gener-
ally considered directly related to the disorder (e.g., other
psychopathology or behavioral, cognitive, or personality
phenotypes), since the association was seen by the age of
7 years—an age at which the probability of children in this
population sample having schizophrenia or schizophrenia-
spectrum disorders was very low. This is an important obser-
vation that is likely to be relevant for analyses of any popula-
tion data, particularly in longitudinal studies. Given the high
levels of pleiotropy for psychiatric and behavioral phenotypes,
it is highly plausible that the mechanism for genetic risk of
schizophrenia operates on nonparticipation through such asso-
ciated phenotypes, which are collectively more common in the
population than schizophrenia alone. Additional research is
needed to further investigate the speciﬁc mechanisms through
which this genetic risk is associated with nonparticipation in
population studies. Another possibility includes active gene-
environment correlation, whereby genetic risk inﬂuences like-
lihood of exposure to environmental factors.
Regardless of the exact mechanisms, the plausible impor-
tance of subclinical phenotypes in nonparticipation further
supports a quantitative trait model of psychiatric phenotypes,
suggesting that there is no clear boundary between the pres-
ence and absence of an adverse phenotypic outcome and that
genetic risk is probably distributed along a continuous liabil-
ity scale. Indeed, a recent study of autism and variation in re-
lated social-communicative traits in the population supported
such a model, by highlighting that both common and rare ge-
netic variants operate on a continuum of behavioral and de-
velopmental traits (23).
If genetic risk of schizophrenia is associated with study non-
participation but schizophrenia phenotype is not (conditional
on genetic risk), then analyses of schizophrenia as an outcome
in longitudinal studies would probably not be biased if genetic
riskwere included as an exposure in the analytical model. If, on
the other hand, a phenotype is associated with nonparticipation
independently of genetic risk, then it is likely that analyses of
schizophrenia as an outcome will be biased by the nonrandom
missingness of this phenotype even with inclusion of genetic
risk in themodel. Furthermore, given that schizophrenia genetic
risk is associated with attrition in cohort studies, complete-case
analyses could lead to collider bias, affecting associations be-
tween genetic risk score and other exposures, such as substance
use, that also lead to nonparticipation.
It is clear that further work is needed to elucidate the mech-
anism through which genetic risk operates to result in a given
phenotype, such as nonparticipation in a longitudinal study.
The method of PRS analysis provides the potential to help
with this process. For instance, the association between in-
creased genetic risk of schizophrenia and schizophrenia as
an outcome is partly mediated through family history of psy-
chiatric illness (24), and as GWAS sample sizes continue to
increase, such analyses are likely to shed further light on our
understanding of disease risk.
In the secondary analyses including both child and mater-
nal PRS in a single analytical model, maternal PRS appeared
not to contribute unique variance to the association with
missing data. However, there were consistent associations
of child PRS with nonparticipation at all data collection
time points. This ﬁnding suggests that additional genetic
risk factors beyond those carried by the mother inﬂuence
the likelihood of mothers and children not returning question-
naires or attending the clinic visits.
It is possible that the current study underestimated the effect
size of the association between PRS in mothers and nonpar-
ticipation because some mothers with higher PRS may have
not enrolled in the study at all or may not have provided a
DNA sample and so were not part of the analyses. Genetic
data were available for 57% of the sample for participants
alive at 1 year, and these individuals differed with regard
to all covariates except sex in comparison with those without
genetic data (see Table 1). DNA samples were collected from
ALSPAC children and mothers over a number of years and
came from a variety of sources, including umbilical cord
blood (at birth), whole blood drawn when the child was 7
years of age, and cell lines generated from blood collected
at ages 9–17 years. Thus, it is likely that persons at higher ge-
netic risk for schizophrenia could have dropped out of data
collection prior to a DNA sample being obtained. This is an
important limitation of the results and is likely to have resulted
in underestimation of the effect sizes. Indeed, there was a clear
pattern of persons with missing genetic data being more likely
to have missing phenotype data across all of the data collec-
tion time points examined (see Web Table 3).
There were other limitations as well. Firstly, genetic data
from fathers were not available. Secondly, aswith other studies
utilizing the PRSmethod, the effect sizes (particularly in terms
of variance explained) were not very high. A third issue is that
other potential correlates of nonparticipation (e.g., child’s in-
telligence quotient (IQ)) were not taken into account in this
study. The reason for this is that wemade an effort tomaximize
the number of samples that could be analyzed by utilizing cor-
relates of nonparticipation gathered early on in the study. IQ
was measured when the children were 7 years old; therefore,
including this variable drastically reduces the sample size
and power of the analyses. However, when IQ is included,
the effect sizes remain comparable to those shown in Table 3
(results available from ﬁrst author on request).
Despite these limitations, the results of this study show a
consistent pattern of association between genetic risk of
schizophrenia and nonparticipation by study mothers and
children in data collection at numerous time points across
childhood and adolescence. These results have important im-
plications for genetic studies that utilize psychiatric-related
phenotypes ascertained using a longitudinal cohort design
and possibly also for studies conducted in the general popu-
lation, which may suffer from selection biases. The results
suggest that persons at higher genetic risk for schizophrenia
and related phenotypes are likely to be underrepresented in
longitudinal studies, which may decrease the statistical
power for any analyses of schizophrenia and other related
phenotypes, both in terms of categorical diagnoses and in
terms of quantitative population traits. Our results suggest
that analyses with schizophrenia as an outcome may be bi-
ased by the nonrandom missingness of this phenotype, espe-
cially if genetic risk factors are not taken into account. It is
possible that the missing-at-random assumption of multiple
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imputation models may still not be met even after inclusion of
variables related to family history, socioeconomic position, and
childhood behavioral and emotional problems. These results
open up possibilities for future research into nonparticipation
in longitudinal studies—for example, regarding whether inclu-
sion of genetic risk scores in imputation of missing data might
allow associations to be estimated with less bias.
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